In silico analysis of the prognostic value of FAS mRNA in malignancies
Conclusions: In summary, the dominant function of FAS may vary in different malignancies. FAS mRNA expression was correlated with better OS in breast cancer, gastric cancer and lung cancer, but worse OS in pancreatic cancer and AML. We also suggested that FAS mRNA expression could be a potential biomarker for cabozantinib and erlotinib.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Zhigang Chen, Jun Wu, Hailin Xu, Xiuyan Yu, Ke Wang Tags: Research Paper Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Adenocarcinoma | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Colorectal Cancer | Gastric (Stomach) Cancer | Gastroenterology | Head and Neck Cancer | Leukemia | Lung Cancer | Non-Small Cell Lung Cancer | Ovarian Cancer | Ovaries | Pancreas | Pancreatic Cancer | Smokers | Study | Tarceva